{
    "clinical_study": {
        "@rank": "80573", 
        "arm_group": [
            {
                "arm_group_label": "Placebo Group", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Drug group", 
                "arm_group_type": "Experimental", 
                "description": "7 Keto-DHEA"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this research study is to test the effectiveness of 7-Keto DHEA in reducing\n      symptoms of Post-Traumatic Stress Disorder (PTSD)."
        }, 
        "brief_title": "7-Keto DHEA for the Treatment of PTSD", 
        "condition": "PTSD", 
        "condition_browse": {
            "mesh_term": "Stress Disorders, Post-Traumatic"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Veteran status and enrolled for care in the Veteran Health Administration\n\n          -  Ages 18-64\n\n          -  Primary diagnosis of PTSD as assess by the clinician administered PTSD scale and\n             independent clinical mental health evaluation\n\n        Exclusion Criteria:\n\n          -  psychosis\n\n          -  Dementia\n\n          -  Active alcohol and/or substance abuse or dependence\n\n          -  Active suicidal or homicidal ideation\n\n          -  Medical concerns that would exclude use of 7-Keto DHEA"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "64 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01861847", 
            "org_study_id": "2905"
        }, 
        "intervention": [
            {
                "arm_group_label": "Drug group", 
                "intervention_name": "7-Keto Dehydroepiandrosterone", 
                "intervention_type": "Drug", 
                "other_name": "7-Keto DHEA"
            }, 
            {
                "arm_group_label": "Placebo Group", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Dehydroepiandrosterone"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 23, 2013", 
        "location": {
            "contact": {
                "email": "carol.obrien1@va.gov", 
                "last_name": "Carol O'Brien, Ph.D.", 
                "phone": "727-398-6661", 
                "phone_ext": "7579"
            }, 
            "facility": {
                "address": {
                    "city": "Bay Pines", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "33744"
                }, 
                "name": "Bay Pines VA Healthcare System"
            }, 
            "investigator": {
                "last_name": "Carol O'Brien, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "7-Keto DHEA for the Treatment of PTSD", 
        "overall_contact": {
            "email": "carol.obrien1@va.gov", 
            "last_name": "Carol O'Brien, Ph.D.", 
            "phone": "727-398-6661", 
            "phone_ext": "7579"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Data and Safety Monitoring Board", 
                "United States: Federal Government", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Outcome measures include analysis in symptoms of depression, anxiety, stress, trauma, and improved memory and cognitive functioning after treatment with 7-Keto DHEA.  Measures will include psychological questionnaires as follows:\nPCL-C (PTSD Checklist) ASP (Associated Symptoms of PTSD Scale) TSI (Trauma Symptom Inventory) DES (Dissociative Experience Scale) BDI-II (Beck Depression Inventory - II) BSI (Brief Symptom Inventory) QOLI (Quality of Life Inventory)", 
                "measure": "Psychological benefits of 7-Keto DHEA (Dehydroepiandrosterone) in Veterans suffering from PTSD participating in the intervention through questionnaires and corresponding measurement of blood work for amounts of DHEA.", 
                "safety_issue": "Yes", 
                "time_frame": "Four months"
            }, 
            {
                "description": "DHEA (DHEA-S) concentrations (serum, saliva) are often elevated in men and women suffering from PTSD including that related to combat experience. Several studies have shown an association between higher levels of DHEA/DHEA-S and abatement of PTSD symptoms.  Outcome measures include analysis  of medical assessments via blood work; CBC (Complete Blood Count), Cortisol, and DHEA sulfate level", 
                "measure": "Physiological benefits of 7-Keto DHEA (Dehydroepiandrosterone) in Veterans suffering from PTSD participating in the intervention through questionnaires and corresponding measurement of blood work for amounts of DHEA.", 
                "safety_issue": "Yes", 
                "time_frame": "Four months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01861847"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bay Pines VA Healthcare System", 
            "investigator_full_name": "Carol O'Brien", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Bay Pines VA Healthcare System", 
        "sponsors": {
            "collaborator": {
                "agency": "Humanetics Corporation", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Bay Pines VA Healthcare System", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}